| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8803072 | Revista Colombiana de Ortopedia y Traumatología | 2016 | 8 Pages |
Abstract
Apixaban is a cost-saving thromboprophylaxis strategy in patients undergoing THR or TKR in Colombia, as it prevents more VTE events, bleeding, and all-cause death, generating more LYG and QALYs, and its discounted costs are lower.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Jaime E. Ordóñez, Arlex U. Palacios,